Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine in chronic idiopathic urticaria
IRCT138710041520N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Salcrozine in chronic idiopathic urticaria (CIU), sponsored by Shiraz University of Medical Sciences. Started Jun 2008; status: completed.
02
Drugs
Salcrozine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on IRCT138710041520N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138710041520N1.